Macy's, Inc.

Vancouver, British Columbia--(Newsfile Corp. - September 22, 2026) - Myriad Uranium Corp. (CSE: M) (OTCQB: MYRUF) (FSE: C3Q) ("Myriad" or the "Company") is pleased to announce the results of an initial testing campaign conducted by DISA Uranium™ Corporation ("DISA Uranium") in 2026 with samples from Myriad Uranium. The primary objective of testing was to determine how efficiently DISA's high-pressure slurry ablation technology ("HPSA™") could concentrate uranium and improve recovery of uranium from the concentrated mass fraction.

Macy's NYSE: M executives told investors at the Goldman Sachs Global Consumer and Retail Conference that the company's “A Bold New Chapter” strategy is producing sales growth, improved customer-service metrics and progress across its Macy's, Bloomingdale's and Bluemercury banners.

Macy's, Inc. (M) Presents at Goldman Sachs Global Consumer and Retail Conference Transcript

M raises its 2026 outlook after stronger Q2 results, but heavier Q3 investment and soft earnings guidance keep near-term risks in focus.